Loyal Launches Nationwide, 1,000-Dog Clinical Trial for Drug to Extend Healthy Lifespan in Senior Dogs

SAN FRANCISCO–(BUSINESS WIRE)–Biotech company Loyal launches nationwide, 1,000-dog clinical trial for its LOY-002 drug to extend healthy lifespan in senior dogs.
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks